Subpages Investors & Media Shares Share Issue Ownership Structure Corporate Governance Calendar Financial Reports Press Releases Investors & Media Contact
Ten largest shareholders as of June 30, 2026
Name Class A-shares Class B-shares Share capital % Votes %
ANNWALL & ROTHSCHILD INVESTMENT AB 453 283 721 351 8,72 29,94
NORTHERN TRUST COMPANY 1 697 863 12,60 9,67
SIX SIS AG W8IMY 1 539 657 11,43 8,77
FJÄRDE AP-FONDEN 1 344 000 9,98 7,66
ÅLANDSBANKEN ABP 456 581 3,39 2,60
AVANZA PENSION 399 606 2,97 2,28
DANGOOR, DAVID 370 455 2,75 2,11
P.R BANQUE PIXTET & CIE SA 321 169 2,38 1,83
IBKR FINANCIAL SERVICES AG 265 966 1,97 1,52
NORDNET PENSIONSFÖRSÄKRING AB 237 045 1,76 1,35
Sum 10 largest shareholders 453 283 7 353 693 57,95 67,73
Other shareholders 5 664 444 42,05 32,27
Total 453,283 13,018,137 100 100
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.